Featured Headlines Feed for DRTX Headlines for Durata Therapeutics http://www.rssboard.org/rss-specification Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic Durata Announces Data from Phase I Trial of Dalbavancin http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3537063/durata-announces-data-from-phase-i-trial-of-dalbavancin.aspx?source=itxwebtxt0000015 Benzinga Mon, 29 Apr 2013 07:35:29 GMT UPDATE: Wedbush Lowers PT on Durata Therapeutics on Revised 2013 Total Expense Expectations http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/04/3493418/update-wedbush-lowers-pt-on-durata-therapeutics-on-revis.aspx?source=itxwebtxt0000015 Benzinga Fri, 12 Apr 2013 11:42:51 GMT U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130412-000331&cid=1244&source=itxwebtxt0000015 Smart Money Fri, 12 Apr 2013 06:46:59 GMT Market Close: Big Winners & Losers for April 11, 2013 (ACAD, RAD, MEA, RDHL, INOC, NTIC, LEDS, DRTX, http://www.fool.com/news/xt/247wallst/247wallst.com/2013/04/11/market-close-big-winners-losers-for-april-11-2013-acad-rad-mea-rdhl-inoc-ntic-leds-drtx-ftnt-gnvc/.aspx?source=itxwebtxt0000015 247wallst Thu, 11 Apr 2013 16:29:21 GMT U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130410-000332&cid=1244&source=itxwebtxt0000015 Smart Money Wed, 10 Apr 2013 06:22:59 GMT 3 Speculative Healthcare Companies With High Levels Of Insider Ownership - Part III http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1301031-3-speculative-healthcare-companies-with-high-levels-of-insider-ownership-part-iii.aspx?source=itxwebtxt0000015 Seeking Alpha Tue, 26 Mar 2013 11:36:16 GMT Trius: Topline Data From Second Phase III Trial Of Tedizolid Is Imminent http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1282511-trius-topline-data-from-second-phase-iii-trial-of-tedizolid-is-imminent.aspx?source=itxwebtxt0000015 Seeking Alpha Mon, 18 Mar 2013 08:54:37 GMT 5 Stocks Poised for Breakouts http://www.fool.com/news/xt/thestreet/www.stockpickr.com/5-stocks-poised-breakouts.html-26.aspx?puc=aol&cm_ven=aol&source=itxwebtxt0000015 TheStreet Fri, 15 Mar 2013 13:38:00 GMT UPDATE: Credit Suisse Assumes Durata Therapeutics at Outperform on Valuation, Derisking http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3419819/update-credit-suisse-assumes-durata-therapeutics-at-outp.aspx?source=itxwebtxt0000015 Benzinga Fri, 15 Mar 2013 08:46:02 GMT UPDATE: Wedbush Raises PT to $26 on Durata Therapeutics on Favorable Tax Strategy http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3409174/update-wedbush-raises-pt-to-26-on-durata-therapeutics-on.aspx?source=itxwebtxt0000015 Benzinga Tue, 12 Mar 2013 12:15:36 GMT Durata Therapeutics CEO discusses Q4 2012 Results - Earnings Call Transcript http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1259311-durata-therapeutics-ceo-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015 Seeking Alpha Fri, 08 Mar 2013 11:53:04 GMT UPDATE: Bank of America Raises PT on Durata Therapeutics after Positive Phase 3 Trial Data http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/02/3363884/update-bank-of-america-raises-pt-on-durata-therapeutics-.aspx?source=itxwebtxt0000015 Benzinga Mon, 25 Feb 2013 14:36:07 GMT Durata Sees Positive Results From Dalbavancin Study http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130225-000174&cid=1244&source=itxwebtxt0000015 Smart Money Mon, 25 Feb 2013 07:54:00 GMT Durata Therapeutics: Low Floater With Near-Term Phase III Catalyst http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1103841-durata-therapeutics-low-floater-with-near-term-phase-iii-catalyst.aspx?source=itxwebtxt0000015 Seeking Alpha Wed, 09 Jan 2013 18:15:12 GMT Durata Says EMA Review in Phase 3 Trial of Dalbavancin Met Primary Endpoints http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/01/3215176/durata-says-ema-review-in-phase-3-trial-of-dalbavancin-met-primary-endpoints.aspx?source=itxwebtxt0000015 Benzinga Fri, 04 Jan 2013 08:35:04 GMT 2 Biotech Firms To Consider In The Wake Of Positive Clinical Data http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1058171-2-biotech-firms-to-consider-in-the-wake-of-positive-clinical-data.aspx?source=itxwebtxt0000015 Seeking Alpha Tue, 11 Dec 2012 15:50:31 GMT Durata Therapeutics Announces Phase 3 Clinical Trial Results for Dalbavancin in the Treatment of ABS http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/11/durata-therapeutics-announces-phase-3-clinical-tri/.aspx?source=itxwebtxt0000015 DailyFinance Tue, 11 Dec 2012 08:51:27 GMT Durata Therapeutics to Host Conference Call and Webcast on December 11, 2012 at 9:00AM ET to Present http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/10/durata-therapeutics-to-host-conference-call-and-we/.aspx?source=itxwebtxt0000015 DailyFinance Mon, 10 Dec 2012 16:36:03 GMT Durata Therapeutics Relocating Corporate Headquarters to Chicago http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/11/14/durata-therapeutics-relocating-corporate-headquart/.aspx?source=itxwebtxt0000015 DailyFinance Wed, 14 Nov 2012 10:51:28 GMT Durata Therapeutics Reports Third Quarter 2012 Financial and Corporate Results http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/11/09/durata-therapeutics-reports-third-quarter-2012-fin/.aspx?source=itxwebtxt0000015 DailyFinance Fri, 09 Nov 2012 07:59:01 GMT